Broker’s call: Dr Reddy’s Lab (Hold)
Target: ₹1,449 CMP: ₹1,303 Dr Reddy’s quarterly earnings were above our expectations on the revenue front but lower on earnings.
Continue readingThe Number One Finance & Business Blog!
Target: ₹1,449 CMP: ₹1,303 Dr Reddy’s quarterly earnings were above our expectations on the revenue front but lower on earnings.
Continue readingChoice Broking Target Price: ₹5,715 CMP: ₹5,754.05 LTIMindtree Ltd reported decent Q1-FY25 revenues at $1,096.2 million, up 2.6 per cent
Continue readingTarget: ₹525 CMP: ₹409.35 In Q4FY24, Yatharth Hospital & Trauma Care Services Ltd exhibited strong financial performance across key indicators.
Continue readingTarget: ₹2,096 CMP: ₹1,931.25 During Q3-FY24, Endurance Technologies delivered a lower-than-expected performance, however compared to industry growth, the revenue growth
Continue readingTarget: ₹127 CMP: ₹104.40 Piramal Pharma reported healthy performance in Q2-FY24 which was above our estimate. Revenue stood at ₹1,911.40
Continue reading